Highly portable quantitative screening test for prostate-specific antigen at point of care

Andreeva, 2016, Quantitative lateral flow immunoassay for total prostate specific antigen in serum, Anal. Lett., 49, 579, 10.1080/00032719.2015.1075130 Barbosa, 2014, A lab-in-a-briefcase for rapid prostate specific antigen (PSA) screening from whole blood, Lab Chip, 14, 2918, 10.1039/C4LC00464G Brawley, 2012, Trends in prostate cancer in the United States, J. Natl. Cancer Instit.. Monographs, 2012, 152, 10.1093/jncimonographs/lgs035 Chang, 2016, PSA detection with femtomolar sensitivity and a broad dynamic range using SERS nanoprobes and an area-scanning method, ACS Sens., 1, 645, 10.1021/acssensors.6b00053 Chornokur, 2011, Impedance-based miniaturized biosensor for ultrasensitive and fast prostate-specific antigen detection, J. Sens., 2011, 1, 10.1155/2011/983752 Dong, 2017, A novel immunosensing platform for highly sensitive prostate specific antigen detection based on dual-quenching of photocurrent from CdSe sensitized TiO2 electrode by gold nanoparticles decorated polydopamine nanospheres, Biosens. Bioelectron., 91, 246, 10.1016/j.bios.2016.12.043 Draisma, 2003, Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer, J. Natl. Cancer Instit., 95, 868, 10.1093/jnci/95.12.868 Ertürk, 2015, Real-time prostate-specific antigen detection with prostate-specific antigen imprinted capacitive biosensors, Anal. Chim. Acta, 891, 120, 10.1016/j.aca.2015.07.055 Ertürk, 2016, Microcontact imprinting based surface plasmon resonance (SPR) biosensor for real-time and ultrasensitive detection of prostate specific antigen (PSA) from clinical samples, Sens. Actuators, B, 224, 823, 10.1016/j.snb.2015.10.093 Etzioni, 2008, Quantifying the role of PSA screening in the US prostate cancer mortality decline, Cancer Causes Control, 19, 175, 10.1007/s10552-007-9083-8 Foysal, 2019, Analyte quantity detection from lateral flow assay using a smartphone, Sensors (Basel, Switzerland), 19, 4812, 10.3390/s19214812 Gann, 1995, A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer, JAMA, 273, 289, 10.1001/jama.1995.03520280035036 Gutiérrez-Zúñiga, 2014, Sandwich-type ELISA Impedimetric Immunosensor for Early Detection of Prostate-specific Antigen (PSA) in Human Serum, Procedia Chem., 12, 47, 10.1016/j.proche.2014.12.040 Hewitt, 2018, Exploring racial differences surrounding prostate cancer screening: beliefs and attitudes in community dwelling men attending an urban men’s health event, Am. J. Men's Health, 12, 1929, 10.1177/1557988318784838 Juntunen, 2012, Performance of fluorescent Europium(III) nanoparticles and colloidal gold reporters in lateral flow bioaffinity assay, Anal. Biochem., 428, 31, 10.1016/j.ab.2012.06.005 Kainz, 2021, Eliminating viscosity bias in lateral flow tests, Microsyst. Nanoeng., 7, 72, 10.1038/s41378-021-00296-5 Kavosi, 2014, A highly sensitive prostate-specific antigen immunosensor based on gold nanoparticles/PAMAM dendrimer loaded on MWCNTS/chitosan/ionic liquid nanocomposite, Biosens. Bioelectron., 52, 20, 10.1016/j.bios.2013.08.012 Kensler, 2021, Racial and ethnic variation in PSA testing and prostate cancer incidence following the 2012 USPSTF recommendation, J. Natl. Cancer Instit., 113, 719, 10.1093/jnci/djaa171 Kong, 2015, A novel aptamer-functionalized MoS2 nanosheet fluorescent biosensor for sensitive detection of prostate specific antigen, Anal. Bioanal. Chem., 407, 369, 10.1007/s00216-014-8267-9 Koo, 2016, A guideline of selecting and reporting intraclass correlation coefficients for reliability research, J. Chiropractic Med., 15, 155, 10.1016/j.jcm.2016.02.012 Kost, 1995, Guidelines for point-of-care testing. Improving patient outcomes, Am. J. Clin. Pathol., 104, S111 Lee, 2016, NutriPhone: a mobile platform for low-cost point-of-care quantification of vitamin B12 concentrations, Sci. Rep., 6, 28237, 10.1038/srep28237 Li, 2014, Rapid and quantitative detection of prostate specific antigen with a quantum dot nanobeads-based immunochromatography test strip, ACS Appl. Mater. Interfaces, 6, 6406, 10.1021/am5012782 Lu, 2018, High-yield paper-based quantitative blood separation system, Lab Chip, 18, 3865, 10.1039/C8LC00717A Melegos, 1997, Prostate-specific antigen in female serum, a potential new marker of androgen excess, J. Clin. Endocrinol. Metabolism, 82, 777, 10.1210/jcem.82.3.3792 Miller, 2021, Prostate cancer screening and young black men: can early communication avoid later health disparities?, J. Cancer Educ., 1–6 Morgan, 1996, Age-specific reference ranges for serum prostate-specific antigen in black men, N Engl. J. Med., 335, 304, 10.1056/NEJM199608013350502 Nanocomposix, I., 2021. Gold Nanoshells Retrieved from https://nanocomposix.com/pages/gold-nanoshells. Nelson, 2021, Association of prostate-specific antigen velocity with clinical progression among African American and non-Hispanic white men treated for low-risk prostate cancer with active surveillance, JAMA Network Open, 4, e219452, 10.1001/jamanetworkopen.2021.9452 Noone, 2017, Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013, Cancer Epidemiol., Biomarkers Prevention: Publ. Am. Assoc. Cancer Res., cosponsored by the American Society of Preventive Oncology, 26, 632, 10.1158/1055-9965.EPI-16-0520 Partin, 1996, Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis, J. Urol., 155, 1336, 10.1016/S0022-5347(01)66260-8 Pei, 2015, Graphene oxide quantum dots@silver core–shell nanocrystals as turn-on fluorescent nanoprobe for ultrasensitive detection of prostate specific antigen, Biosens. Bioelectron., 74, 909, 10.1016/j.bios.2015.07.056 Posthuma-Trumpie, 2009, Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey, Anal. Bioanal. Chem., 393, 569, 10.1007/s00216-008-2287-2 Rafique, 2015, Electrochemical immunosensor for prostate-specific antigens using a label-free second antibody based on silica nanoparticles and polymer brush, Bioelectrochemistry, 101, 75, 10.1016/j.bioelechem.2014.08.001 Siegel, 2021, Cancer Statistics, 2021, CA Cancer J. Clin., 71, 7, 10.3322/caac.21654 So, 2003, Prostate specific antigen: an updated review, Can. J. Urol., 10, 2040 Srinivasan, 2018, ironPhone: Mobile device-coupled point-of-care diagnostics for assessment of iron status by quantification of serum ferritin, Biosens. Bioelectron., 99, 115, 10.1016/j.bios.2017.07.038 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660 Uludag, 2012, Cancer biomarker detection in serum samples using surface plasmon resonance and quartz crystal microbalance sensors with nanoparticle signal amplification, Anal. Chem., 84, 5898, 10.1021/ac300278p USPSTF, 2018. Screening for prostate cancer: US preventive services task force recommendation statement. JAMA 319(18), 1901-1913. doi:10.1001/jama.2018.3710 Wang, 2017, Using reduced graphene oxide-Ca:CdSe nanocomposite to enhance photoelectrochemical activity of gold nanoparticles functionalized tungsten oxide for highly sensitive prostate specific antigen detection, Biosens. Bioelectron., 96, 239, 10.1016/j.bios.2017.04.052 Wood, 1991, “Matrix effects” in immunoassays, Scand J. Clin. Lab Invest. Suppl., 51, 105, 10.3109/00365519109104608 Woods-Burnham, 2018, Physician consultations, prostate cancer knowledge, and PSA screening of African American men in the era of shared decision-making, Am. J. Mens Health, 12, 751, 10.1177/1557988318763673 Wu, 2016, Label-free electrochemiluminescent immunosensor for detection of prostate specific antigen based on aminated graphene quantum dots and carboxyl graphene quantum dots, Sci. Rep., 6, 20511, 10.1038/srep20511 Yan, 2012, A disposable electrochemical immunosensor based on carbon screen-printed electrodes for the detection of prostate specific antigen, Biosens. Bioelectron., 38, 355, 10.1016/j.bios.2012.06.019 Zhang, 2017, Visible-light driven Photoelectrochemical Immunosensor Based on SnS2@mpg-C3N4 for Detection of Prostate Specific Antigen, Sci. Rep., 7, 4629, 10.1038/s41598-017-04924-x